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In Brief
Yeh et al. characterize a novel role for the
deubiquitinase USP37 in mitotic
progression. USP37 associates with
cohesin and regulates sister chromatid
resolution through stabilization of
chromatin-associated WAPL, a protein
required for cohesin release in prophase.
Specifically, USP37 regulates WAPL
deubiquitylation in mitosis.
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A bipolar mitotic spindle facilitates the equal segre-
gation of chromosomes to two daughter cells. To
achieve bipolar attachment of microtubules to ki-
netochores of sister chromatids, chromatids must
remain paired after replication. This cohesion is
mediated by the conserved cohesin complex
comprised of SMC1, SMC3, SCC1, and either SA1
or SA2 in humans. Because defects in spindle as-
sembly or sister chromatid cohesion can lead to
aneuploidy in daughter cells, proper regulation of
these processes is essential for fidelity in chromo-
some segregation [1]. In an RNAi screen for regula-
tors of spindle assembly, we identify the deubiqui-
tinase USP37 as a regulator of mitotic progression,
centrosome integrity, and chromosome alignment.
USP37 associates with cohesin and contributes
to sister chromatid resolution. Cohesion defects
are rescued by expression of an RNAi-resis-
tant USP37, but not the catalytically impaired
USP37C350A mutant. Further, USP37 associates
with WAPL, a negative regulator of cohesion
necessary for cohesin release in prophase [2, 3],
in a manner dependent on USP37’s second and
third ubiquitin-interacting motifs. Depletion of
USP37 reduces the stability of chromatin-asso-
ciated WAPL and increases the fraction of WAPL
that is more heavily ubiquitylated in mitosis.
Consistently, overexpression of USP37C350A re-
sults in increased modification of WAPL, and
addition of purified USP37WT, but not USP37C350A,
to WAPL immunoprecipitates results in a reduc-
tion of ubiquitylated products. Taken together,
our results ascribe a novel function for USP37 in
mitotic progression and further suggest that
USP37 positively regulates the stability of chro-
matin-associated WAPL to facilitate sister chro-
matid resolution.2290 Current Biology 25, 2290–2299, August 31, 2015 ª2015 ElsevieRESULTS AND DISCUSSION
USP37 Is a Novel Regulator of Mitotic Spindle Assembly
and Normal Mitotic Progression
To characterize novel regulators of mitotic progression, we per-
formed an RNAi screen in HeLa cells on 296 genes we previously
showed yield an increase in mitotic index (MI) upon their deple-
tion (Figure S1A; Table S1) [4]. We employed a two-stage imag-
ing approach to automatically image mitotic cells at high resolu-
tion (Figure S1A). First, cells were imaged at low resolution (103;
N.A. = 0.40) for DAPI and phospho-histone H3 (pSer10) to
segment mitotic cells by stage coordinates (X, Y, and Z) and to
calculate MI. Second, using the mapped coordinates, individual
mitotic cells were imaged at higher resolution (403; N.A. = 1.35)
for a-tubulin, pericentrin (PCNT), and DAPI in order to assess
multiple parameters related to normal mitotic progression (Fig-
ure S1B; Table S1). These parameters include defects in spindle
polarity, such asmonopolar or multipolar spindles; chromosome
misalignment, such as lagging chromosomes or failure of chro-
mosomes to congress at the metaphase plate; and centrosome
integrity, which when perturbed results in fragmentation and
dissociation of the pericentriolar material from the centrioles
(Figure S1B) [5]. Knockdown of 38% of tested genes results in
a significant increase in MI (average Z score > 2.0; Table S1),
suggesting that these genes contribute to normal mitotic pro-
gression. Genes that result in the greatest increase in MI after
depletion (average Z score > 6.0) includemany known regulators
of spindle assembly, such as tubulin subunits, motor proteins,
kinetochore components, and centrosome proteins (Table S1).
In our RNAi screen, we observed that depletion of the deubi-
quitinase USP37, which contains three ubiquitin-interacting
motifs (UIMs) and a ubiquitin-specific peptidase (USP) family
domain (Figure 1A), results in a significant increase in MI
(average Z score = 6.4 ± 2.7; Table S1), suggesting a role for
USP37 in normal mitotic progression. We found this interesting
because USP37 has been implicated in cell proliferation and
transformation [6, 7] as well as in cell-cycle regulation, where
during the G1/S transition, CDK2 phosphorylates and activates
USP37 to stabilize the anaphase-promoting complex/CDH1
(APCCDH1) substrate cyclin A [8]. A pool of USP37 is targeted
for degradation at the G2/M transition by the SKP1-cullin-
F-box-protein/bTRCP complex (SCFbTRCP), whereas a secondr Ltd All rights reserved
pool of USP37 is targeted for degradation in G1 by APCCDH1;
however, a mitotic pool of USP37 remains [9]. Although the
bulk of mitotic USP37 is thought to be inactive [8], we cannot
exclude the possibility that a small fraction of USP37 remains
active during mitosis or that USP37 may contribute to mitotic
progression by stabilizing mitotic regulators in interphase prior
to mitotic entry. Further analysis of spindle morphology in
USP37-depleted cells revealed defects in chromosome align-
ment (average Z score = 3.8 ± 0.5; Figure S1C) and centrosome
integrity (average Z score = 8.8 ± 2.2) in mitosis (Table S1), sug-
gesting that USP37 may regulate chromosome segregation and
spindle assembly.
Indeed, we rescued mitotic defects in USP37-depleted cells
by expression of RNAi-resistant GFP-USP37 (GFP-USP37WT;
Figures 1B–1D and S1D). Knockdown of USP37 in HeLa cells
expressing GFP alone results in 51% ± 11% of mitotic cells
with abnormal spindle morphology (Figure 1C), including chro-
mosome misalignment, centrosome fragmentation, and multi-
polar spindles (Figure 1B), compared to 14% ± 7% of mitotic
control cells (Figure 1C). Expression of GFP-USP37WT in
USP37-depleted cells results in 20% ± 11% of mitotic cells
with abnormal spindle morphology (Figure 1C), demonstrating
that the chromosome congression and spindle assembly defects
observed in mitosis upon USP37 depletion are not caused by an
off-target effect. By contrast, expression of a GFP-tagged,
RNAi-resistant, catalytically impaired mutant of USP37 (GFP-
USP37C350A) in USP37-depleted cells results in 63% ± 9% of
mitotic cells with abnormal spindle morphology (Figure 1C), indi-
cating that the deubiquitinase activity of USP37 is necessary for
bipolar spindle assembly.
To understand how mitotic defects arise in USP37-depleted
cells, we performed time-lapse imaging of HeLa cells expressing
NEDD1-GFP (Movie S1), a marker of centrosomes and spindle
microtubules [10]. In USP37-depleted cells, mitotic cells begin
with a bipolar spindle, but centrosome fragmentation leads to
formation of multipolar spindles (Figure S1E; Movie S1). Centro-
some fragmentation in USP37-depleted cells may be due to an
imbalance of forces within the spindle, whereby microtubule-
focusing activity at spindle poles is not properly countered by
microtubule attachment and tension at kinetochores [11].
Consistent with an imbalance of spindle forces, we observed a
reduction in the kinetochore localization of HEC1 (Figure 1E), a
key microtubule-binding protein at kinetochores, to 0.53 ± 0.04
a.u. compared to 1.00 ± 0.05 a.u. in control cells (Figure 1F).
As well, we observed a reduction in interkinetochore tension
from 1.60 ± 0.05 mm in control cells to 0.62 ± 0.02 mm in
USP37-depleted cells (Figure 1G). Time-lapse imaging of HeLa
cells expressing H2B-GFP (Figure 1H; Movie S1) revealed
that USP37-depleted mitotic cells have a higher frequency of
anaphases with lagging chromosomes of 45% ± 12% com-
pared to 20% ± 3% in control cells (Figure 1I). Together,
these results demonstrate that USP37 is required for bipolar
spindle assembly, chromosome segregation, and normal mitotic
progression.
USP37 Associates with Chromosome and Cohesion
Factors
To gain a better understanding of howUSP37 regulates chromo-
some segregation and spindle assembly, we employed the prox-Current Biology 25, 2290–imity-dependent biotin identification (BioID) method to identify
USP37-interacting partners [12]. Briefly, two 293 T-REx cell
pools expressing a tetracycline (Tet)-regulatable Flag-BirA*-
USP37 protein were created. USP37 was thus N-terminally
tagged with a mutant E. coli biotin ligase enzyme (R118G or
BirA*). Notably, the BirA* protein retains the ability to activate
biotin, yet exhibits a reduced affinity for the activated molecule
[13]; highly reactive biotinoyl-AMP therefore simply diffuses
away from BirA* and reacts with nearby amine groups, including
those present on lysine residues in nearby polypeptides. Bio-
tinylated proteins can be affinity purified by streptavidin pull-
down and identified using mass spectrometry. Because BioID
does not require preservation of endogenous protein-protein
interactions for their identification, lysis can be performed under
denaturing conditions, allowing for detection of poorly soluble
proteins, such as chromatin-associated and centrosome-asso-
ciated proteins [14, 15], which can go undetected in traditional
affinity purification-mass spectrometry methods. In 293 T-REx
cells treated with Tet and biotin, FLAG-BirA*-USP37 is ex-
pressed (Figure 2A) and localizes to the nucleus (Figure 2B), as
previously described [16]. Biotinylated proteins are also de-
tected in the nucleus (Figure 2B), suggesting that USP37 may
interact with nuclear and/or chromatin-associated proteins.
Comparing BioID results for cells expressing FLAG-BirA*-
USP37 to cells expressing the FLAG-BirA* tag alone, we identi-
fied a number of known USP37-interacting partners (Figure S2A;
Table S2), including components of the SCF (FBXW11, BTRC,
and SKP1) and APC complexes (CDC27/ANAPC3, ANAPC4,
ANAPC7, ANAPC1, CDC16/ANAPC6, ANAPC5, ANAPC13,
ANAPC16, C11ORF51/ANAPC15, CDC23, and CDC26), vali-
dating the BioID approach to identify USP37-interacting proteins
[8, 9]. Strikingly, BioID of FLAG-BirA*-USP37 also revealed po-
tential interactions (SAINT > 0.8) between USP37 and cohesin
subunits (SMC3, SMC1, SCC1, SA2, and SA1), as well as regu-
lators of cohesion (WAPL and NIPBL; Figure S2A; Table S2).
Both USP37 and cohesin exhibit similar localization patterns
(Figure 1J; Movie S2), such that both localize to the nucleus in
interphase but have cytosolic distributions in mitosis and both
can associate with chromatin, as determined by western blot
of the chromatin fraction prepared from HeLa cells (Figure S4A).
Given the mitotic delay and chromosome segregation errors we
observed in USP37-depleted cells (Figures 1H and 1I; Movie S1)
and that our study (Figure S2B) and others have implicated cohe-
sion factors in regulating these processes [17, 18], we hypothe-
sized that USP37 may interact with and regulate cohesin.
Indeed, cohesin subunits MYC-SMC1, MYC-SCC1, MYC-SA2,
and GFP-SMC3 co-immunoprecipitate with FLAG-USP37 in
HEK293 cells (Figure 2C), confirming that USP37 associates
with cohesin. Further, these interactions were confirmed in
HeLa cells where endogenous SA2, SMC3, and SCC1 co-immu-
noprecipitate with stably expressed GFP-USP37, but not with
GFP tag alone (Figures S2C and S2D).
USP37 Regulates Sister Chromatid Resolution and
Associates with WAPL
To determine whether USP37 regulates chromosome cohesion,
we performed metaphase spreads on USP37-depleted HeLa
cells treated with nocodazole (100 ng/ml; 90 min; Figures 3A
and 3B). In control cells, mitotic chromosomes are resolved,2299, August 31, 2015 ª2015 Elsevier Ltd All rights reserved 2291
BC D
DNA PCNT α-Tubulin
DNA
PCNT
α-Tubulin
C
on
tro
l
U
S
P
37
R
N
A
i
H
A
1 34
1
70
4
72
3
80
6
82
5
82
8
84
7
95
2
97
9
a.a.
U
IM
1
U
IM
2
U
IM
3
USP Family
I J
USP37
GAPDH
C
on
tro
l
U
S
P
37
RNAi:
130
35
- 00:10
G
FP
-U
S
P
37
00:00 00:10 00:30 00:50 00:60 01:10 01:30
F
C
on
tro
l
U
S
P
37
DNA
HEC1
CREST HEC1CREST α-Tubulin
HEC1
CREST
α-Tubulin
R
N
A
i
E G
C
on
tro
l
- 00:10 00:00 00:10 00:30 00:40 01:0000:20
U
S
P
37
- 00:10 00:00 00:10 00:30 01:10 02:30 03:10
R
N
A
i
03:20 03:30
Figure 1. USP37 Is a Novel Regulator of Mitotic Spindle Assembly in Human Cells
(A) Schematic of USP37. USP37 is a 979-amino-acid protein with an ubiquitin-specific peptidase (USP) family domain (blue) and three ubiquitin-interactingmotifs
(UIMs) (red). Amino acid (aa) positions are denoted above the cartoon.
(B) Depletion of USP37 in HeLa cells results in abnormal mitotic spindle morphology. HeLa cells were transfected with esiRNA-targeting control (Luciferase)
or USP37. Cells were fixed at 48 hr post-transfection and stained for DAPI (DNA; blue), pericentrin (red), and a-tubulin (green). The scale bar represents
10 mm.
(C) Quantification of abnormal spindle morphology in USP37-depleted HeLa cells and genetic rescue by expression of RNAi-resistant USP37. Control or USP37-
depleted HeLa cells were induced with Tet (0.1 mg/ml; 24 hr) to express GFP or RNAi-resistant GFP-USP37WT or GFP-USP37C350A, where the catalytic Cys
residue of the deubiquitinase is mutated to Ala. Abnormal spindle morphology for 50 mitotic cells per condition was scored. Averages of three replicates are
shown. Error bars are SEM.
(D) Western blot of control and USP37-depleted HeLa cells with rabbit anti-USP37 antibody (raised against aa 4–124 of USP37). Arrow indicates band specific to
USP37.
(E) Reduction in kinetochore localization of HEC1 in cells depleted of USP37. Immunostaining of CREST, HEC1, and a-tubulin in control and USP37-depleted
HeLa cells. The scale bar represents 10 mm.
(F) Quantification ofmeanHEC1 kinetochore intensity (arbitrary units [a.u.]) normalized to CREST from experiment described in (E). Averages from three replicates
are shown. Intensities from ten cells (ten kinetochores/cell) were measured per replicate (total of 100 kinetochores per replicate). Error bars are SEM.
(legend continued on next page)
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Figure 2. BioID of FLAG-BirA*-USP37
Identifies Regulators of Sister Chromatid
Cohesion
(A) Validating expression of FLAG-BirA*-USP37
and biotinylation in HEK293 T-REx cells by western
blot. Anti-FLAG (upper panel) andStreptavidin-HRP
(lower panel) western blot of Tet-inducible HEK293
T-REx cells expressing FLAG-BirA*-USP37 in ± Tet
(1 mg/ml; 24 hr) and ± biotin (50 mM; 24 hr) is shown.
(B) Localization of FLAG-BirA*-USP37 in HEK293
T-REx cells. Immunofluorescence staining of Tet-
inducible HEK293 T-REx cells expressing FLAG-
BirA*-USP37 in ± Tet (1 mg/ml) and ± biotin (50 mM)
with Streptavidin and antibodies against FLAG and
USP37 is shown. The scale bar represents 10 mm.
(C) USP37 co-immunoprecipitates with subunits of
cohesin in HEK293 cells. HEK293 cells co-trans-
fected with either FLAG-USP37 or FLAG vector
and indicated plasmids were harvested and lysed
24 hr post-transfection. Anti-FLAG immunopre-
cipitation was performed on lysates. Anti-FLAG,
anti-MYC, and anti-GFP western blots were per-
formed on immunoprecipitates. See also Figure S2
and Table S2.displaying a classic ‘‘x’’-shape where sister chromatids are
tightly linked at the centromere, but chromosome arms are
separated (Figure 3A, first panel). Knockdown of WAPL, a pro-
tein required for removal of cohesin from chromosome arms in
prophase, is used as a control for the unresolved chromatids
phenotype (Figures 3A, second panel, and 3B), where chromo-
somes appear paired along chromosome arms [2, 3], and
knockdown of Sororin, a protein required for cohesion, is
used as a control for the single chromatids phenotype (Fig-
ure 3A, fourth panel) [19, 20]. Knockdown of USP37 results in
17% ± 3% of metaphases with unresolved sister chromatids,
an approximately 6-fold increase from 3% ± 2% in control cells
(Figures 3A, third panel, and 3C). In USP37-depleted cells,
expression of RNAi-resistant GFP-USP37WT rescues the defect
in sister chromatid resolution with only 6% ± 3% of meta-
phases displaying unresolved sister chromatids (Figure 3C).
By contrast, expression of RNAi-resistant GFP-USP37C350A
does not rescue the defect in sister chromatid resolution with
17% ± 1% of metaphases displaying unresolved chromatids
(Figure 3C). Together, these results suggest that USP37 may
regulate sister chromatid resolution in a catalytically dependent
manner.
To determine whether the defect in sister chromatid resolution
is due to the presence of cohesin on chromosomes, cells were
co-depleted of USP37 and the cohesin subunit SCC1 (Figures
S3A–S3C). In USP37/USP37-depleted cells, we observed just(G) Reduced interkinetochore tension in USP37-depleted mitotic cells from exp
measured as distance between HEC1 signals for paired sister kinetochores, as
displayed. Ten cells (ten sister kinetochores/cell) were measured per replicate (t
(H) USP37 contributes to normal mitotic progression and chromosome alignment.
expressing H2B-GFP is shown. Time is indicated in hours. The scale bar represe
(I) Quantification of percentage of anaphaseswith lagging chromosomes in contro
of three replicates are shown, at least 40 cells counted per condition per replica
(J) Localization of GFP-USP37 in HeLa cells. Live-cell, time-lapse imaging of Tet-i
localizes to the nucleus in interphase and cytosol in mitosis. Time is indicated in
Triple asterisks (***) denote p < 0.0001, double asterisks (**) denote p < 0.01, and
Current Biology 25, 2290–1% ± 1% of metaphases with single chromatids but 19% ±
4% of metaphases with unresolved sister chromatids. By
contrast, co-depletion of USP37/SCC1 results in 79% ± 16%
of metaphases with single chromatids, similar to SCC1/SCC1-
depleted cells with 83% ± 16% of metaphases with single
chromatids (Figure S3C). These results indicate that defects in
resolution are dependent on the presence of cohesin on chromo-
somes duringmitosis in USP37-depleted cells. Consistent with a
role for USP37 in sister chromatid resolution, we did not observe
any significant changes in the loading of cohesin subunits SMC1,
SMC3, SCC1, and SA2 onto chromatin (Figures S2E and S2F).
We also observed that depletion of USP37 did not affect total
protein levels of SMC1, SMC3, SCC1, and SA2 (Figure S3D).
Collectively, these results support a role for USP37 and, specif-
ically, USP37’s deubiquitinase activity in regulating sister chro-
matid resolution.
The removal of cohesin from chromosomes in mitosis occurs
in two phases [21]. The first phase is removal of cohesin from
chromosome arms in prophase through opening of its SMC3-
SCC1 exit gate [22–25] in a process mediated by WAPL [2, 3],
PLK1, and AURKB kinases, in which PLK1 phosphorylates SA2
[26–28]. At this stage, cohesin at centromeres is protected
from removal by SGO1 and PP2A [29, 30]. In anaphase, after bio-
rientation is achieved and the spindle assembly checkpoint is
satisfied, Separase cleaves SCC1, leading to release of cohesin
from centromeres [31, 32]. We find that depletion of USP37eriment described in (E). Quantification of mean interkinetochore tension (mm)
determined by CREST staining, is shown. Averages from three replicates are
otal of 100 sister kinetochores per replicate). Error bars are SEM.
Live-cell, time-lapse imaging of control and USP37-depleted HeLa Kyoto cells
nts 10 mm. See also Movie S1.
l and USP37-depletedHeLa cells expressing H2B-GFP imaged in (H). Averages
te. Error bars are SEM.
nducible HeLa GFP-USP37 cells induced with Tet (1 mg/ml; 24 hr). GFP-USP37
hours. The scale bar represents 10 mm. See also Movie S2.
single asterisk (*) denotes p < 0.05. See also Figure S1 and Table S1.
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Figure 3. USP37 Regulates Sister Chromatid Resolution and Interacts with WAPL, a Negative Regulator of Cohesion
(A) Defects in sister chromatid resolution in USP37-depleted metaphases. Control, WAPL-, USP37-, and Sororin-depleted HeLa cells were treated with noco-
dazole (100 ng/ml; 90 min), fixed in methanol/acetic acid solution, dropped onto glass slides, and stained with DAPI (DNA). The scale bar represents 20 mm.
(legend continued on next page)
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results in a less-penetrant resolution defect than depletion of
WAPL (Figure 3B). This may be due to insufficient knockdown
of USP37, or USP37 may play a less-predominant role in sister
chromatid resolution than WAPL. However, because both
USP37 and WAPL negatively regulate cohesion, we hypothe-
sized that USP37 may interact with WAPL to facilitate sister
chromatid resolution. Indeed, GFP-WAPL co-immunoprecipi-
tates with FLAG-USP37 in HEK293 cells (Figure 3D), indicating
that WAPL associates with USP37. Further, we demonstrate
that endogenous WAPL co-immunoprecipitates with GFP-
USP37 stably expressed from a Tet-regulatable promoter in
HeLa cells (Figure 3E), confirming the association between
USP37 and WAPL.
Similar to USP37, WAPL is also required for proper chromo-
some segregation in mitosis [18, 33]. Further, WAPL is needed
to concentrate AURKB at centromeres in mitosis. Conse-
quently, WAPL-depleted cells are delayed in correcting faulty
kinetochore-microtubule attachments [18]. Using a similar error
correction assay [34], where cells are treated with monastrol,
washed out, and released into MG132, we observed that
USP37-depleted cells also display defects in error correction
(Figure S3E). At 90 min after monastrol washout, 86% ± 3%
of USP37-depleted cells displayed defects in chromosome
alignment, compared to only 40% ± 11% of control cells (Fig-
ure S3F). Therefore, in addition to a role in sister chromatid res-
olution, both USP37 and WAPL contribute to normal chromo-
some segregation and bioriented kinetochore-microtubule
attachment.
Given these similar phenotypes and that the deubiquitinase
activity of USP37 contributes to its role in sister chromatid reso-
lution, we hypothesized that USP37 may regulate WAPL by deu-
biquitylation. To test our hypothesis, we performed His-Ubiquitin
pull-downs under denaturing conditions to determine whether
WAPL is ubiquitylated. Denaturing conditions were used to pre-
vent detection of non-covalent protein-protein interactions.
In cycling cells stably expressing Tet-inducible His-Ubiquitin,
WAPL is pulled down with Ni-NTA beads only when expression
of His-Ub is induced with Tet (Figure S3G), suggesting that
WAPL is ubiquitylated. To further assess cell-cycle-dependent
ubiquitylation of WAPL, cells were treated with hydroxyurea to
enrich for cells in S phase; RO-3306, a CDK1 inhibitor, to enrich
for cells in G2 phase; or nocodazole to enrich for cells in early(B) Quantification of cohesion phenotypes in control, WAPL-, and USP37-deple
unresolved sister chromatids in USP37-depleted cells. Fifty metaphases were
are SEM.
(C) Quantification of sister chromatid resolution defects in control and USP37-d
resistant GFP-USP37C350A. Sister chromatid resolution defects in USP37-deplete
Fifty metaphases were scored per condition. Averages from three replicates are
asterisk (*) denotes p < 0.05.
(D) USP37 co-immunoprecipitates with WAPL in HEK293 cells. Western blots on a
with FLAG-USP37 and GFP-WAPL are shown.
(E) Endogenous WAPL associates with stably expressed GFP-USP37 in HeLa c
were induced with Tet (1 mg/ml; 24 hr), harvested, and lysed. Anti-GFP immunop
were performed on immunoprecipitates and inputs, of which 33% of immunopre
(F) WAPL is ubiquitylated during the cell cycle. His-Ubiquitin pull-downs (His-P
HEK293 cells expressing Tet-inducible His-Ubiquitin treated with Tet (1 mg/ml; 1
nocodazole (NOC) (70 ng/ml; 16 hr), as indicated, using Ni-NTA agarose resin. A
(G) The interaction between USP37 and WAPL is dependent on the UIMs of US
transfected with either FLAG-USP37WT or an ubiquitin-binding USP37 mutant (F
Current Biology 25, 2290–mitosis (Figure S3H). WAPL is pulled down with His-Ub under
denaturing conditions in all tested treatments (Figure 3F), indi-
cating that ubiquitylated WAPL is detected throughout the cell
cycle.
We expected that, if USP37 deubiquitylatesWAPL, the ubiqui-
tin-binding activities of USP37 would be critical for the interac-
tion between USP37 and WAPL. Ubiquitin-binding USP37
mutants were generated (Figure S3I), and in vitro pull-downs
with tetra-Ubiquitin (Ub4) (K48-, K63-, and K11-linked) chains
were performed to confirm that these mutants are ubiquitin-
binding deficient (Figure S3J). Mutations in UIM2 and UIM3
abrogate binding to K48- and K63-linked Ub4 chains, similar to
published work [16], but also to K11-linked Ub4 chains, which
are produced by APCCDH1, the E3 ligase associated with
USP37 [8, 35]. To determine whether the physical association
between USP37 and WAPL is dependent on the ubiquitin-bind-
ing activity of USP37, the same mutations were introduced into
full-length FLAG-USP37 and expressed in HEK293 cells.
Mutation of all three UIMs (FLAG-USP37m123) impairs the inter-
action with MYC-WAPL (Figure 3G); however, a UIM1 (FLAG-
USP37m1) mutant maintains the ability to associate with WAPL,
indicating that the ubiquitin-binding activities of UIM2 and
UIM3 are necessary for interaction with WAPL. Indeed, mutation
of only UIM2 and UIM3 (FLAG-USP37m23) also impairs the
interaction with WAPL (Figure 3G). These results confirm the
contribution of UIM2 and UIM3 of USP37 to binding ubiquitin
conjugates in vitro and, in particular, to mediating an interaction
with WAPL in vivo.
USP37 Regulates the Deubiquitylation of WAPL and the
Association of WAPL on Chromatin
Because the interaction between USP37 and WAPL is depen-
dent on the ubiquitin-binding domains of USP37, we hypo-
thesized that USP37 may regulate WAPL’s association with
chromatin and/or its stability through deubiquitylation. First,
WAPL levels were assessed by western blot in whole-cell ex-
tract (WCE), chromatin, and soluble fractions prepared from
asynchronous HeLa cells depleted of USP37 (Figure S4A).
As expected, WAPL is detected in both soluble and chromatin
fractions, confirming that WAPL does associate with chro-
matin [2, 3]. In USP37-depleted cells, WAPL levels are re-
duced 2-fold in WCE (Figure S4A), indicating that USP37ted HeLa cells. Distribution of cohesion phenotypes indicates an increase in
scored per condition. Averages from three replicates are shown. Error bars
epleted HeLa cells expressing GFP, RNAi-resistant GFP-USP37WT, or RNAi-
d cells are rescued by expression of GFP-USP37WT, but not GFP-USP37C350A.
shown. Error bars are SEM. Double asterisks (**) denote p < 0.01, and single
nti-FLAG and anti-GFP immunoprecipitates from HEK293 cells co-transfected
ells. HeLa cells stably expressing Tet-inducible GFP-USP37 or GFP tag alone
recipitation was performed on lysates. Anti-GFP and anti-WAPL western blots
cipitates and 2% of inputs were analyzed by SDS-PAGE.
Ds) were performed under guanidine hydrochloride denaturing conditions on
6 hr) and hydroxyurea (HU) (500 mM; 16 hr), RO-3306 (RO) (10 mM; 16 hr), or
nti-WAPL western blot on the pull-downs was performed.
P37. Western blots on anti-FLAG immunoprecipitates from HEK293 cells co-
LAG-USP37m1/m123/m23) and MYC-WAPL are shown. See also Figure S3.
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Figure 4. USP37 Regulates the Stability and Deubiquitylation of WAPL
(A) WAPL levels in chromatin fraction of USP37-depleted HeLa cells synchronized by double-thymidine block. Control and USP37-depleted HeLa cells were
synchronized by double-thymidine (2 mM) block and harvested at indicated time points (hr) after washout and release from the second block. Cells were lysed
and chromatin fractions were prepared by sonication, and western blot was performed with indicated antibodies. WAPL intensities normalized to Histone H3 are
indicated.
(B) Turnover ofWAPL on chromatin is increased in USP37-depleted cells. Control andUSP37-depletedHeLa cells were synchronized by double-thymidine block,
released into cycloheximide (CHX) (10 mg/ml), and harvested at the indicated time points (hr). Cells were lysed, chromatin fractions prepared, and western blots
performed using the indicated antibodies.
(legend continued on next page)
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regulates WAPL but perhaps only a small fraction of WAPL,
for instance, only at a particular time or place during the
cell cycle. Next, we assessed WAPL levels in cells synchro-
nized by double-thymidine block and found that chromatin-
associated WAPL levels decrease when cells enter mitosis,
approximately 8–10 hr post-thymidine release (Figure 4A).
This observation is consistent with the dynamic behavior of
WAPL at the G2/M transition [2, 3]. However, whereas soluble
WAPL levels in USP37-depleted cells are steady, similar to
control (Figure S4B), chromatin-associated WAPL levels
decrease precociously in USP37-depleted cells (Figure 4A),
approximately 4–6 hr post-thymidine release. The decrease
in chromatin-associated WAPL may be due to accelerated
entry into mitosis and/or premature release of WAPL from
chromatin in USP37-depleted cells, leading to defects in sister
chromatid resolution.
To investigate these possibilities, we monitored the onset
of mitotic entry and detected an increase in phospho-histone
H3 levels at 4 hr post-thymidine release in USP37-depleted
cells compared to an increase at 8 hr in control cells (Figure 4A),
suggesting that accelerated entry into mitosis may contribute
to the premature decrease in chromatin-associated WAPL
levels. To investigate the second possibility that USP37 may
regulate WAPL’s association with chromatin more directly,
the stability of chromatin-associated WAPL was assessed
by cycloheximide time course (Figure 4B). Strikingly, in the
presence of cycloheximide, chromatin-associated WAPL levels
decrease more rapidly (t1/2 = 1.6 hr) in cells depleted of USP37
than in control cells (t1/2 = 2.8 hr; Figure 4C), whereas the turn-
over of other cohesion regulators (SCC1 and SA2) is compara-
ble in control and USP37-depleted cells (Figure 4B). These
results suggest that USP37 specifically contributes to the stabi-
lization of chromatin-associated WAPL. Live-cell, time-lapse
imaging of HeLa cells stably expressing WAPL tagged with
GFP from a bacterial artificial chromosome shows that the
localization of WAPL to the nucleus in interphase and in cytosol
in mitosis is similar in control and USP37-depleted cells (Fig-
ure S4C; Movie S1) [36]. This is not surprising, considering it
is difficult to detect endogenous cohesin on chromosomes in
mitosis [3, 26, 28] and that only a fraction of WAPL may asso-
ciate with and be stabilized by USP37. Intriguingly, in co-immu-
noprecipitation experiments, levels of WAPL are consistently
higher in cells expressing FLAG-USP37WT compared to cells
expressing FLAG vector (Figures 3D and 3G), suggesting that
overexpression of USP37 may stabilize WAPL levels. Consis-
tent with these observations, levels of GFP-WAPL are higher(C) Plot of chromatin-associated WAPL levels at indicated time points from ex
normalized to Histone H3 levels.
(D) Ubiquitylation of WAPL is regulated by USP37 in nocodazole-treated cells. His
control, USP37-depleted, and WAPL-depleted HEK293 cells expressing Tet-indu
RO (10 mM; 16 hr), or NOC (70 ng/ml; 16 hr), as indicated, using Ni-NTA agarose
was performed.
(E) Overexpression of catalytically impaired USP37C350A mutant results in higher-
plasmids expressing FLAG-tagged deubiquitinases, as indicated, harvested, and
intensities normalized to a-tubulin are indicated.
(F) USP37 deubiquitylatesWAPL immunoprecipitates in vitro. HEK293 cells transie
harvested, lysed, and anti-GFP immunoprecipitation performed. Buffer alone, p
noprecipitates, as indicated, nutated at 37C for 30 min, and anti-MYC-Ubiquiti
USP37 to immunoprecipitates. MYC-Ubiquitin intensities normalized to GFP-WA
Current Biology 25, 2290–when FLAG-USP37, but not when another deubiquitinase
(FLAG-USP11 and -USP2) or FLAG tag alone is co-expressed
(Figure S4D). Taken together, these results support a specific
role for USP37 in stabilizing the levels of chromatin-associated
WAPL.
Because USP37 stabilizes chromatin-associated WAPL and
the ubiquitin-binding activities of USP37 are important for its
association with WAPL, we next aimed to determine whether
USP37 regulates deubiquitylation of WAPL. In control cells,
WAPL is pulled down with His-Ubiquitin under denaturing condi-
tions throughout the cell cycle (Figure 4D). Varying molecular
weight bands of WAPL are observed, representing WAPL modi-
fied with ubiquitin to varying extents. Importantly, these bands
are reduced in WAPL-depleted cells (Figure 4D), indicating
they are specific to ubiquitylated WAPL. In nocodazole-treated,
USP37-depleted cells, we observed a reduction in lower-molec-
ular-weight bands of WAPL (Figure 4D, short exposure), but
higher-molecular-weight bands of WAPL are still pulled down
with His-Ubiquitin (Figure 4D, long exposure), suggesting that
a greater pool of WAPL is more heavily modified with Ubiquitin
when USP37 is depleted in early mitosis. Further, overexpres-
sion of mutant FLAG-USP37C350A results in a higher-molecu-
lar-weight smear of WAPL (Figure 4E), indicating that the
deubiquitinase activity of USP37 contributes to regulation of
WAPL modifications. Notably, we did not observe an increase
in the levels of endogenousWAPLwhen FLAG-USP37WT is over-
expressed, possibly because USP37 only regulates a fraction of
WAPL in cells on chromatin during mitosis. Next, to investigate
whether USP37 can directly deubiquitylate WAPL, we purified
full-length USP37WT and USP37C350A from Sf9 insect cells
and added either USP37WT, USP37C350A, or buffer alone to
anti-GFP-WAPL immunoprecipitates from HEK293 cells co-
expressing GFP-WAPL and MYC-Ubiquitin (Figure 4F). When
buffer alone is added, ubiquitylation is detected in anti-GFP-
WAPL immunoprecipitates. Importantly, when USP37WT, but
not USP37C350A, is added, ubiquitylation is reduced (Figure 4F),
indicating that USP37 can directly deubiquitylate WAPL and/or
WAPL-associated proteins in vitro. Collectively, these results
support a role for USP37 in regulating the deubiquitylation of
WAPL in mitosis.
In this report, we identify a novel role for USP37 in mitotic
progression. We show that impairing USP37’s deubiquitinase
activity perturbs chromosome segregation and cohesion. We
further reveal that USP37 contributes to the prophase pathway
of cohesin removal from chromosome arms. USP37 interacts
with WAPL, a negative regulator of cohesion, through its UIMsperiment described in (B). WAPL intensities were measured in ImageJ and
-PDs were performed under guanidine hydrochloride denaturing conditions on
cible His-Ubiquitin and treated with Tet (1 mg/ml; 16 hr) and HU (500 mM; 16 hr),
resin. Anti-WAPL western blot on the pull-downs and whole-cell extract (WCE)
molecular-weight smear of WAPL. HeLa cells were transiently transfected with
lysed. Western blot was performed on lysates with indicated antibodies. WAPL
ntly transfectedwith plasmids expressingGFP-WAPL andMYC-ubiquitin were
urified USP37WT, or USP37C350A (from Sf9 insect cells) was added to immu-
n western blot performed. Coomassie stain indicates addition of 3 mg purified
PL immunoprecipitates’ intensities are indicated. See also Figure S4.
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and regulates the stability of chromatin-associated WAPL. Spe-
cifically, USP37 regulates deubiquitylation of WAPL in mitosis.
Therefore, the available data point to WAPL as the most likely
USP37 substrate in the regulation of chromosome cohesion.
Given the critical role of WAPL in the prophase pathway, it will
be interesting to discern whether USP37 contributes to other
WAPL-dependent processes, such as chromatin structure or
protecting cohesin from cleavage by Separase [33]. However,
we note that roles for USP37 in sister chromatid resolution
through additional mechanisms may exist, including regulation
of Sororin activity [37], mitotic phosphorylation of SA2 [26–28],
sister chromatid decatenation [33, 38], or in the transcriptional
regulation and/or organizational properties of chromatin [39,
40]. In summary, in addition to its described role in cell-cycle
regulation [8], USP37 also regulates sister chromatid cohesion,
thereby illuminating a critical role for deubiquitylation in themain-
tenance of cohesion.
EXPERIMENTAL PROCEDURES
Please see Supplemental Experimental Procedures.
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